Patient Square Capital’s Celcuity CELC Stock Holding History

Patient Square Capital’s Portfolio CELC Stock Details CELC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-95,000	Closed	-$10.8M	–	26
2026 Q1	$10.8M	Sell	95,000 -25,000	-21%	-$2.73M	1.92%	14
2025 Q4	$12M	Buy	120,000 +20,000	+20%	+$1.64M	2.56%	10
2025 Q3	$4.94M	Buy	+100,000	New	+$4M	1.32%	14

Other funds holding CELC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Patient Square Capital's CELC Position: Q2 2026 in Review

Patient Square Capital sold out of Celcuity (CELC) in Q2 2026, closing a stake of 95,000 shares — an estimated $10.8M sold.

Patient Square Capital first reported a position in CELC in Q3 2025 and held it in 3 quarters. The position peaked at $12M in Q4 2025. 273 funds tracked by Wall St. Rank hold CELC as of Q2 2026.

Patient Square Capital reported no remaining Celcuity position as of Q2 2026 after selling out during the quarter.
Patient Square Capital sold 95,000 Celcuity shares in Q2 2026, an estimated $10.8M.
Patient Square Capital first reported a position in Celcuity in Q3 2025 and held it in 3 quarters.
Patient Square Capital's Celcuity position peaked at $12M in Q4 2025.
273 funds tracked by Wall St. Rank held Celcuity as of Q2 2026.

Based on Patient Square Capital's 13F filing for Q2 2026, filed 12 Aug 2026.